NASDAQ: EXOZ
Exozymes Inc Earnings Dates, Reports, Calls

Exozymes earnings were -$7.7M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest EXOZ earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.4M, up 27.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EXOZ reported annual earnings of -$5.9M, with 187.5% growth.

EXOZ earnings history

Current Revenue
$0.0
Current Earnings
-$7.7M
Current Profit Margin
0%

EXOZ Return on Equity

Current Company
-134.4%
Current Industry
-10%
Current Market
30.7%
EXOZ's Return on Equity (-134.4%)... subscribe to Premium to read more.
High Return on Equity Performance

EXOZ undefined

Current Company
-81.6%
Current Industry
-0.2%
EXOZ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EXOZ announces earnings.

EXOZ undefined

Current Company
-94.44%
Current Industry
6.4%

EXOZ vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EXOZ-$7.68M-$7.71MN/A-$1.02
CGTX-$32.73M-$32.99MN/A-$0.67
CSBR$4.42M$2.95M+114.07%$0.21
CRBP-$57.15M-$57.95MN/A-$4.74
SEER-$75.84M-$82.44MN/A-$1.39

Exozymes Earnings Reports & History FAQ

What were Exozymes's earnings last quarter?

Exozymes (NASDAQ: EXOZ) reported Q2 2025 earnings per share (EPS) of -$0.28, up 27.27% year over year. Total EXOZ earnings for the quarter were -$2.36 million. In the same quarter last year, Exozymes's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Exozymes stock.

Is Exozymes profitable or losing money?

As of the last Exozymes earnings report, Exozymes is currently losing money. Exozymes's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$7.71 million, a 93.3% increase year over year.

What was EXOZ's earnings growth in the past year?

As of Exozymes's earnings date in Q3 2025, Exozymes's earnings has grown year over year. EXOZ earnings in the past year totalled -$7.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.